EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hybrid B- and T-Cell Immunity Associates With Protection Against Breakthrough Infection After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Avon Longitudinal Study of Parents and Children (ALSPAC) Participants

Holly E Baum iD, Marianna Santopaolo, Ore Francis, Emily J Milodowski, Katrina Entwistle iD, Elizabeth Oliver, Benjamin Hitchings iD, Divya Diamond, Amy C Thomas, Ruth E Mitchell, Milla Kibble, Kapil Gupta und 19 weitere

The Journal of Infectious Diseases · 14.08.2025 · 232 (2) · e327-e340

DOI: 10.1093/infdis/jiaf246 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 20.05.2025. Verfasst von Holly E Baum und 30 weiteren Autor:innen. Beteiligte Einrichtung: School of Cellular and Molecular Medicine, Faculty of Health and Life Sciences, University of Bristol, Bristol, United Kingdom. Hauptthemen laut MEDLINE: COVID-19, T-Lymphocytes, SARS-CoV-2, COVID-19 Vaccines. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Academy of Medical Sciences, CRUK Integrative Cancer Epidemiology Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Immunological memory to vaccination and viral infection involves the coordinated action of B and T cells; thus, integrated analysis of these 2 components is critical for understanding their respective contributions to protection against breakthrough infections (BIs) after vaccination.

Methods

We investigated cellular and humoral immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and/or vaccination in 300 adult participants from the Avon Longitudinal Study of Parents and Children (ALSPAC). Participants were grouped by those with (cases) and without (controls) a history of SARS-CoV-2 infection. To provide a quantitative correlate for protection against BI in the 8-month period after the study, Youden index thresholds were calculated for all immune measures analyzed.

Results

The magnitude of antibody and T-cell responses following the second vaccine dose was associated with protection against BI in participants with a history of SARS-CoV-2 infection (cases), but not in infection-naive controls. Over 8 months of follow-up, 2 threshold combinations provided the best performance for protection against BI in cases: (i) anti-spike immunoglobulin G (IgG) (≥666.4 binding antibody units [BAU]/mL) combined with anti-nucleocapsid pan-immunoglobulin (pan-Ig) (≥0.1332 BAU/mL) and (ii) spike 1–specific T cells (≥195.6 spot-forming units/106 peripheral blood mononuclear cells) combined with anti-N pan-Ig (≥0.1332 BAU/mL). Both combinations offered 100% specificity for detecting cases without BI, with sensitivities of 83.3% and 72.2%, respectively.

Conclusions

Collectively, these results suggest that hybrid B- and T-cell immunity offers superior protection from BI after coronavirus disease 2019 (COVID-19) vaccination, and this finding has implications for designing next-generation COVID-19 vaccines that are capable of eliciting immunity to a broader repertoire of SARS-CoV-2 proteins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19T-LymphocytesSARS-CoV-2COVID-19 VaccinesB-LymphocytesHumansLongitudinal StudiesMaleFemaleAdultAntibodies, ViralMiddle AgedVaccinationImmunity, CellularChildImmunologic MemoryYoung AdultAdolescentBreakthrough Infections

Stichwörter der Autor:innen

ALSPACSARS-CoV-2breakthrough infectionhybrid immunityvaccination

Substanzen

COVID-19 VaccinesAntibodies, Viral

Autor:innen und Institutionen

  • School of Cellular and Molecular Medicine, Faculty of Health and Life Sciences, University of Bristol, Bristol, United Kingdom.
  • Bristol Vaccine Centre, University of Bristol, Bristol, United Kingdom.
  • Bristol Veterinary School, Faculty of Health and Life Sciences, University of Bristol, Bristol, United Kingdom.
  • Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
  • Department of Applied Mathematics and Theoretical Physics, University of Cambridge, Cambridge, United Kingdom.
  • Department of Twin Research and Genetic Epidemiology, King's College London, London, United Kingdom.

ORCID-Profile: Holly E Baum, Katrina Entwistle, Benjamin Hitchings, Paul Klenerman, Imre Berger, Anu Goenka, Susan Ring, Kate Northstone, Nicholas J Timpson, Linda Wooldridge, Alice Halliday, Laura Rivino

Förderung

  • Wellcome Trust
  • Academy of Medical Sciences
  • CRUK Integrative Cancer Epidemiology Programme
  • University's Alumni and Friends
  • ALSPAC
  • Medical Research Council
  • University of Bristol
  • Integrative Epidemiology Unit

Zitieren

APA

Baum, H. E., Santopaolo, M., Francis, O., Milodowski, E. J., Entwistle, K., Oliver, E., Hitchings, B., Diamond, D., Thomas, A. C., Mitchell, R. E., Kibble, M., Gupta, K., Di Bartolo, N., Klenerman, P., Brown, A., Morales-Aza, B., Oliver, J., Berger, I., Toye, A. M., …, & Rivino, L. (2025). Hybrid B- and T-Cell Immunity Associates With Protection Against Breakthrough Infection After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Avon Longitudinal Study of Parents and Children (ALSPAC) Participants. The Journal of Infectious Diseases, 232(2), e327-e340. https://doi.org/10.1093/infdis/jiaf246

Vancouver

Baum HE, Santopaolo M, Francis O, Milodowski EJ, Entwistle K, Oliver E, et al. Hybrid B- and T-Cell Immunity Associates With Protection Against Breakthrough Infection After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Avon Longitudinal Study of Parents and Children (ALSPAC) Participants. The Journal of Infectious Diseases. 2025;232(2):e327-e340. doi:10.1093/infdis/jiaf246

BibTeX
@article{Baum2025,
  author = {Baum, Holly E and Santopaolo, Marianna and Francis, Ore and Milodowski, Emily J and Entwistle, Katrina and Oliver, Elizabeth and Hitchings, Benjamin and Diamond, Divya and Thomas, Amy C and Mitchell, Ruth E and Kibble, Milla and Gupta, Kapil and Di Bartolo, Natalie and Klenerman, Paul and Brown, Anthony and Morales-Aza, Begonia and Oliver, Jennifer and Berger, Imre and Toye, Ash M and Finn, Adam and Goenka, Anu and Davidson, Andrew D and Ring, Susan and Molloy, Lynn and Lewcock, Melanie and Northstone, Kate and Roth, Firona and Timpson, Nicholas J and Wooldridge, Linda and Halliday, Alice and Rivino, Laura},
  title = {Hybrid B- and T-Cell Immunity Associates With Protection Against Breakthrough Infection After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Avon Longitudinal Study of Parents and Children (ALSPAC) Participants},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  volume = {232},
  number = {2},
  pages = {e327--e340},
  doi = {10.1093/infdis/jiaf246}
}
Kostenlos starten →